Send me real-time posts from this site at my email
Motley Fool

Teladoc Crushes Q3 Estimates

A breakout stock of the coronavirus era, Teladoc Health (NYSE: TDOC) delivered a third quarter that trounced analyst estimates.

The period saw the telemedicine services specialist book just under $289 million in revenue, which was more than double the Q3 2019 figure, it reported on Wednesday. The company's net loss, however, deepened to $35.9 million, from the year-ago $20.3 million. On an adjusted basis, the latest shortfall was $0.13 per share.

Regardless, both numbers convincingly beat analyst expectations. On average, they predicted almost $282 million on the top line, and a much deeper adjusted per-share net loss of $0.32.

Using the Teladoc interface. Image source: Teladoc Health.

Teladoc continues to benefit from the dramatic rise in popularity of remote videoconferencing services (in its specific case, doctor visits) during the ever-lengthening coronavirus pandemic. New client partnerships with companies and organizations such as Spain's telecom incumbent Telefonica and Johns Hopkins University have also helped boost revenue.

Additionally, "We are seeing significant market success and consistent growth in member visits throughout all of our commercial channels," CEO Jason Gorevic said.

Teladoc also proffered estimates for its current fourth quarter and the full fiscal year. It believes revenue for the latter will range from just over $1 billion to nearly $1.02 billion, with a per-share net loss of $1.32 to $1.36.

Teladoc has attracted no small amount of criticism lately because of the announcement in August that it agreed to acquire Livongo Health in a deal valued at $18.5 billion. Some observers are concerned that Livongo is not a good fit, while others balk at the rich price the consistently loss-making Teladoc will be paying for its big new asset.

10 stocks we like better than Teladoc Health
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Teladoc Health wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of October 20, 2020

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Livongo Health Inc and Teladoc Health. The Motley Fool has a disclosure policy.


Popular posts

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue